{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:13:50Z","timestamp":1791728030777,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fragility fractures are a consequence of osteoporosis and the strongest indicator of sustaining a future fracture. Effective fracture prevention strategies are therefore needed to reduce the incidence of fragility fractures. Fracture Liaison Services (FLS) are globally recognized as the most effective approach. Inspired by their success, the Danish Health Authority recommended nationwide implementation of prevention programs. With limited funding, the fracture prevention program at Aarhus University Hospital (AUH) was established in 2022 as a modified version. Here, we describe the implementation with focus on patient capture, treatment uptake, collaboration with primary care physicians, and implementation challenges. A retrospective single-center cohort study was conducted. We retrieved information from the hospital registries. Eligible patients were those\u2009\u2265\u200950 years of age who sustained a fracture of the hip, pelvis, spine, distal forearm, or shoulder. Twenty-four months after the implementation, 2363 patients with a fracture were identified. Excluding patients not eligible for the program (n\u2009=\u20091096, 46%), 890 DXAs were performed. Patients diagnosed with osteoporosis following their attendance in the program accounted for 22% (n\u2009=\u2009198). Sixty-five percent were potentially eligible for bone anabolic treatment. The fracture prevention program has systematized the identification of patients presenting with a fragility fracture, and identified osteoporosis in 22% of the patients, and ensured a successful collaboration with the primary care physicians. Despite lacking some components of a full FLS, we have demonstrated that it is possible to successfully establish an FLS modified according to available resources and identify patients at high risk of future fractures.<\/jats:p>","DOI":"10.1007\/s00223-026-01478-x","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:49:57Z","timestamp":1769150997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementation of a Modified Fracture Liaison Service at Aarhus University Hospital: A 2-Year Retrospective Cohort Study"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-6396","authenticated-orcid":false,"given":"Vivi-Nelli","family":"M\u00e4kinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"S\u00f8lling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Harsl\u00f8f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente L.","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"1","key":"1478_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01138-1","volume":"17","author":"CE Gill","year":"2022","unstructured":"Gill CE, Mitchell PJ, Clark J, Cornish J, Fergusson P, Gilchrist N et al (2022) Experience of a systematic approach to care and prevention of fragility fractures in New Zealand. Arch Osteoporos 17(1):108","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1478_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00223-018-0476-3","volume":"104","author":"RMH Tei","year":"2019","unstructured":"Tei RMH, Ramlau-Hansen CH, Plana-Ripoll O, Brink O, Langdahl BL (2019) OFELIA: prevalence of osteoporosis in fragility fracture patients. Calcif Tissue Int 104(1):102\u2013114","journal-title":"Calcif Tissue Int"},{"issue":"3 Suppl","key":"1478_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000192","volume":"5","author":"SL Kates","year":"2022","unstructured":"Kates SL, Miclau T (2022) The fracture liaison service: its history, current state, how it works, and future directions. OTA Int 5(3 Suppl):e192","journal-title":"OTA Int"},{"key":"1478_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-3-030-87950-1_13","volume-title":"New horizons in osteoporosis management","author":"Y El Miedany","year":"2022","unstructured":"El Miedany Y (2022) Imminent fracture risk. In: El Miedany Y (ed) New horizons in osteoporosis management. Springer International Publishing, Cham, pp 369\u2013386"},{"key":"1478_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221112904","volume":"13","author":"R Palui","year":"2022","unstructured":"Palui R, Durgia H, Sahoo J, Naik D, Kamalanathan S (2022) Timing of osteoporosis therapies following fracture: the current status. Ther Adv Endocrinol Metab 13:20420188221112904","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"1478_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMp2409086","volume":"392","author":"N Napoli","year":"2025","unstructured":"Napoli N, Ebeling PR, Kiel DP (2025) Coordinating multidisciplinary care\u2014improving outcomes after fragility fractures. N Engl J Med 392(2):109\u2013111","journal-title":"N Engl J Med"},{"issue":"12","key":"1478_CR7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00198-003-1507-z","volume":"14","author":"AR McLellan","year":"2003","unstructured":"McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14(12):1028\u20131034","journal-title":"Osteoporos Int"},{"issue":"1","key":"1478_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1573397118666220510162127","volume":"19","author":"S Patel","year":"2023","unstructured":"Patel S, Daniels NF, Lim JA, Zhou AK, Thahir A, Krkovic M (2023) The importance of fracture liaison services to the healthcare system: a review. Curr Rheumatol Rev 19(1):36\u201341","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"1478_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01108-7","volume":"17","author":"B Stolnicki","year":"2022","unstructured":"Stolnicki B, In\u00e1cio AM, Tutiya KK, Vieira LFT, Javaid MK, Cal\u00f3 M (2022) How to initiate and develop fracture liaison services (FLS). Recommendations from the IOF capture the fracture\u00ae FLS mentors in Brazil. Arch Osteoporos 17(1):63","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1478_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01103-2","volume":"21","author":"P Naik-Panvelkar","year":"2020","unstructured":"Naik-Panvelkar P, Norman S, Elgebaly Z, Elliott J, Pollack A, Thistlethwaite J et al (2020) Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice. BMC Fam Pract 21(1):32","journal-title":"BMC Fam Pract"},{"key":"1478_CR11","first-page":"462","volume":"49","author":"SB Jaglal","year":"2003","unstructured":"Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM et al (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Phys 49:462\u2013468","journal-title":"Can Fam Phys"},{"key":"1478_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/978-3-030-87950-1_16","volume-title":"New horizons in osteoporosis management","author":"Y El Miedany","year":"2022","unstructured":"El Miedany Y (2022) Osteoporosis update for primary care physicians. In: El Miedany Y (ed) New horizons in osteoporosis management. Springer International Publishing, Cham, pp 433\u2013453"},{"issue":"6","key":"1478_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11914-019-00544-8","volume":"17","author":"PJ Mitchell","year":"2019","unstructured":"Mitchell PJ, Cooper C, Fujita M, Halbout P, \u00c5kesson K, Costa M et al (2019) Quality improvement initiatives in fragility fracture care and prevention. Curr Osteoporos Rep 17(6):510\u2013520","journal-title":"Curr Osteoporos Rep"},{"key":"1478_CR14","unstructured":"Udvalgte kroniske sygdomme og sv\u00e6re psykiske lidelser: https:\/\/www.esundhed.dk\/Emner\/Operationer-og-diagnoser\/Udvalgte-kroniske-sygdomme-og-svaere-psykiske-lidelser; 2025 [cited 03-12-2025]. Available from: https:\/\/www.esundhed.dk\/Emner\/Operationer-og-diagnoser\/Udvalgte-kroniske-sygdomme-og-svaere-psykiske-lidelser"},{"key":"1478_CR15","unstructured":"Authorities DH (2024) An overview of osteoporosis care and managment in Denmark. https:\/\/www.sst.dk\/en\/english\/publications\/2018\/Osteoporosis---An-overview-of-osteoporosis-care-and-management-in-Denmark-Summary2018 [cited 2024 29\u201306\u20132024]"},{"key":"1478_CR16","unstructured":"Sundhedsplanl\u00e6gning RV (2024) Vejledende optageomr\u00e5der for hospitalsbehandling i Region Midtjylland. https:\/\/www.fagperson.sundhed.rm.dk\/contentassets\/8ebc0bff53124e498673f6165db0ca7a\/notat-vejledende-optageomrader-2024.pdf; 23\u201302\u20132024."},{"key":"1478_CR17","unstructured":"Midtjylland R (2009) Almen Praksis i Region Midtjylland\u2014Sundhedsaftalen. https:\/\/www.sundhedsaftalen.rm.dk\/siteassets\/samarbejde-med-kommunerne\/sundhedsstyregruppen\/sst-2009\/5.-februar-2009\/praksisplan-22-9.pdf"},{"issue":"8","key":"1478_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT (2014) The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol 29(8):541\u2013549","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1478_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1185\/03007995.2013.851074","volume":"30","author":"ES Siris","year":"2014","unstructured":"Siris ES, Modi A, Tang J, Gandhi S, Sen S (2014) Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis. Curr Med Res Opin 30(1):123\u2013130","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"1478_CR20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00198-021-05890-x","volume":"32","author":"MK Skj\u00f8dt","year":"2021","unstructured":"Skj\u00f8dt MK, Ernst MT, Khalid S, Libanati C, Cooper C, Delmestri A et al (2021) The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications. Osteoporos Int 32(10):1961\u20131971","journal-title":"Osteoporos Int"},{"issue":"1","key":"1478_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.archger.2008.06.007","volume":"49","author":"P L\u00fcthje","year":"2009","unstructured":"L\u00fcthje P, Nurmi-L\u00fcthje I, Kaukonen J-P, Kuurne S, Naboulsi H, Kataja M (2009) Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr 49(1):153\u2013157","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"1478_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00198-003-1544-7","volume":"15","author":"MJM Panneman","year":"2004","unstructured":"Panneman MJM, Lips P, Sen SS, Herings RMC (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15(2):120\u2013124","journal-title":"Osteoporos Int"},{"issue":"7","key":"1478_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s001980170077","volume":"12","author":"H Castel","year":"2001","unstructured":"Castel H, Bonneh DY, Sherf M, Liel Y (2001) Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures. Osteoporos Int 12(7):559\u2013564","journal-title":"Osteoporos Int"},{"issue":"1","key":"1478_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1525-1497.2003.20387.x","volume":"18","author":"C Simonelli","year":"2003","unstructured":"Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA (2003) Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J Gen Intern Med 18(1):17\u201322","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1478_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40520-016-0681-8","volume":"29","author":"S Gonnelli","year":"2017","unstructured":"Gonnelli S, Caffarelli C, Iolascon G, Bertoldo F, Letizia Mauro G, Patti A et al (2017) Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey. Aging Clin Exp Res 29(5):1031\u20131037","journal-title":"Aging Clin Exp Res"},{"key":"1478_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","volume":"111","author":"C-H Wu","year":"2018","unstructured":"Wu C-H, Tu S-T, Chang Y-F, Chan D-C, Chien J-T, Lin C-H et al (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92\u2013100","journal-title":"Bone"},{"issue":"1","key":"1478_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00198-022-06586-6","volume":"34","author":"N Binkley","year":"2023","unstructured":"Binkley N, Schousboe JT, Lix LM, Morin SN, Leslie WD (2023) Should vertebral fracture assessment be performed in fracture liaison service patients with non-vertebral fracture? Osteoporos Int 34(1):129\u2013135","journal-title":"Osteoporos Int"},{"issue":"6","key":"1478_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.57.6.378","volume":"57","author":"DJ Torgerson","year":"1998","unstructured":"Torgerson DJ, Dolan P (1998) Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57(6):378\u2013379","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1478_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jocd.2021.11.009","volume":"25","author":"A Sahota","year":"2022","unstructured":"Sahota A, Desai H, Hershkovica O, Sahota O (2022) Poor attendance for bone densitometry in patients at high risk of subsequent fragility fractures. J Clin Densitom 25(3):380\u2013383","journal-title":"J Clin Densitom"},{"issue":"2","key":"1478_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00198-013-2481-8","volume":"25","author":"DA Eekman","year":"2014","unstructured":"Eekman DA, van Helden SH, Huisman AM, Verhaar HJJ, Bultink IEM, Geusens PP et al (2014) Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int 25(2):701\u2013709","journal-title":"Osteoporos Int"},{"issue":"6","key":"1478_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s001980200053","volume":"13","author":"T Chevalley","year":"2002","unstructured":"Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R (2002) An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 13(6):450\u2013455","journal-title":"Osteoporos Int"},{"issue":"5","key":"1478_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.20945\/2359-3997000000566","volume":"66","author":"L Bandeira","year":"2022","unstructured":"Bandeira L, Lewiecki EM (2022) Anabolic therapy for osteoporosis: update on efficacy and safety. Arch Endocrinol Metab 66(5):707\u2013716","journal-title":"Arch Endocrinol Metab"},{"issue":"10","key":"1478_CR33","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00198-020-05442-9","volume":"31","author":"P van den Berg","year":"2020","unstructured":"van den Berg P, van Haard PMM, Geusens PP, van den Bergh JP, Schweitzer DH (2020) Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires. Osteoporos Int 31(10):2007\u20132015","journal-title":"Osteoporos Int"},{"issue":"4","key":"1478_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11914-013-0177-9","volume":"11","author":"JR Curtis","year":"2013","unstructured":"Curtis JR, Silverman SL (2013) Commentary: the five Ws of a fracture liaison service: why, who, what, where, and how? In osteoporosis, we reap what we sow. Curr Osteoporos Rep 11(4):365\u2013368","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"1478_CR35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00198-024-07181-7","volume":"35","author":"HV Le","year":"2024","unstructured":"Le HV, Van BW, Shahzad H, Teng P, Punatar N, Agrawal G et al (2024) Fracture liaison service\u2014a multidisciplinary approach to osteoporosis management. Osteoporos Int 35(10):1719\u20131727","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01478-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:59:53Z","timestamp":1781629193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01478-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01478-x","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AAS has received lecture fees from Amgen. TH has received speaker fees from UCH, Amgen, AstraZeneca and Astellas Pharma. BL has received fees for advisory board and lectures from UCB, Amgen, Gedeon-Richer, Angitia and Mereo and serves as a consultant for Samsung-Bioepis and EnteraBio. VNM declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"14"}}